DAVIS, Calif.Aug. 14, 2019 /PRNewswire/ — Evolve BioSystems, Inc. today announced findings from a new study that identified healthy, breastfed U.S. infants have alarmingly high levels of antibiotic resistance genes early in life — and how feeding babies a specific strain of Bifidobacterium — B. infantis EVC001 — along with breast milk, lowered the total levels of antibiotic resistance genes in the infant gut microbiome by 90 percent, including a near elimination of bacteria such as Escherichia, Clostridium and Staphylococcus. The paper, published in Antimicrobial Resistance and Infection Control, demonstrates that B. infantis EVC001 (commercially known as Evivo® baby probiotic) works uniquely with breast milk to suppress the growth of potentially pathogenic bacteria that harbor the genes responsible for antibiotic resistance. No other probiotic has demonstrated this benefit.